OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: University of Massachusetts Boston

4 Projects | 4 Researchers | $663,529 Invested

2017

University of Massachusetts Boston

Evgeny Rogaev, PhD

Targeting APOE e4 in Alzheimer's Disease by novel RNA-based therapeutic compounds

  • Funding Amount: $342,429
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: zzAPOE
  • Status: Closed

2015

University of Massachusetts Boston

Paul Thompson, PhD

Inhibiting Neutrophil Extracellular Trap (NET) formation as a novel therapeutic approach to Alzheimer's disease

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Systemic Inflammation
  • Status: Closed

2011

University of Massachusetts Boston

Maria Morabito, PhD

Inhibitors of Mdm2-dependent PSD-95 ubiquitination as therapeutics for Alzheimer's disease

  • Funding Amount: $121,100
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2006

University of Massachusetts Boston

Jianhua Zhou, PhD

Distal cis-elements and compounds that regulate tau splicing

  • Funding Amount: $50,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed